AIM Rule 26
Intercede is quoted on the AIM section of the London Stock Exchange and is subject to the UK City Code on Takeovers and Mergers. The information on this page is disclosed in accordance with Rule 26 of the AIM Rules and was last updated on 18 August 2015.
Nominated adviser and nominated broker
FinnCap, 60 New Broad Street, London, EC2M 1JJ
Corporate finance adviser
Tredoux Capital Ltd, 2A Abercorn Place, London, NW8 9XR
Reporting accountants and auditors
PricewaterhouseCoopers LLP, Cornwall Court, 19 Cornwall Street, Birmingham B3 2DT
Olswang LLP, 90 High Holborn, London, WC1V 6XX
Barclays Bank PLC, 14 Park Row, Nottingham, NG1 6EX
Computershare Investor Services PLC, The Pavilions, Bridgwater Road, Bristol, BS99 6ZZ
Annual and Interim Reports
Year Ended 31 March 2015
Read the full version of Intercede’s 2015 Annual Report.
View Intercede’s 2014 Interim Report.
Year Ended 31 March 2014
Read the full version of Intercede’s 2014 Annual Report.
View Intercede’s 2013 Interim Report.
Year Ended 31 March 2013
Read the full version of Intercede’s 2013 Annual Report.
View Intercede’s 2012 Interim Report.
Year Ended 31 March 2012
Read the full version of Intercede’s 2012 Annual Report.
View Intercede’s 2011 Interim Report.
Description of the business
Find out more about Intercede.
See who Intercede’s Directors are and their responsibilities.
As a company listed on AIM, Intercede Group plc is not required to comply with the requirements of the Combined Code. A number of voluntary disclosures have been made that are not subject to audit.
Board of Directors
The Company is controlled through the Board of Directors which currently comprises two executive and four non-executive directors, two of whom are considered to be independent. All of the directors have extensive business experience.
The Company has historically combined the posts of Chairman and Chief Executive in one person, namely Richard Parris. The Board believes that to separate the roles would be detrimental at this stage of the Group’s development. Ben Drury was appointed as the senior independent non-executive director with effect from 1 April 2015. This is to be an annually rotated position amongst qualifying non-executive directors as recommended by the Nominations Committee and ratified by the Main Board. All directors submit themselves for re-election at least every three years.
Committees of the Board
The Board has established three committees; the Audit Committee, the Remuneration Committee and the Nominations Committee.
The structure of the Board Committees from 1 April 2015 onwards is as follows:
Audit Committee – Royston Hoggarth is the Chairman of the Audit Committee given his ‘recent and relevant’ financial experience in a variety of Chairman, Chief Executive and non-executive director roles and given his prior experience as Chairman of the Axon Group plc Audit Committee. Ben Drury and Rob Chandhok, both of whom are considered to be independent, are also members of the Audit Committee.
Remuneration Committee – Ben Drury has been appointed as the Chairman of the Remuneration Committee which also comprises Royston Hoggarth and Rob Chandhok, thereby providing a majority of independent directors.
Nominations Committee – The Nominations Committee consists of Richard Parris (Chairman) and Rob Chandhok (independent non-executive director).
Relations with shareholders
The Company gives high priority to communications with current and potential future shareholders by means of an active investor relations programme. The principal communication with private investors is through the website (www.intercede.com) and the provision of Annual and Interim Reports. All shareholders will receive at least twenty one clear days’ notice of the Annual General Meeting at which the Directors will be present and available for questions.
The Directors, after having made appropriate enquiries including a review of the Group’s financial forecasts for 2015/16 and 2016/17, have a reasonable expectation that the Group has adequate resources to continue in operational existence for the foreseeable future. For this reason they continue to adopt the going concern basis in preparing the financial statements.
The Board confirms that there is an ongoing process for identifying, evaluating and managing the significant risks faced by Group which complies with the guidance “Internal Control: Guidance for Directors on the Combined Code (The Turnbull Report)”.
The key features of the Group’s internal control systems are as follows:
Group organization and culture
The Board meets regularly, and is responsible for the overall Group strategy, acquisition and divestment policy, approval of major capital expenditure projects and consideration of significant financing matters. It monitors the key business risks and reviews the strategic direction of the Group, its codes of conduct, forward projections and progress towards their achievement. Senior management concentrates on the formulation of strategic proposals to the Board and operational decision making.
Delegation of authority
The Board reserves to itself a range of key decisions to ensure it retains proper direction and control of the Group, whilst delegating authority to individual directors who are responsible for the day to day management of the business.
There is a comprehensive planning system, including regular periodic forecasts which are presented to and approved by the Board. The performance of the Group is reported monthly and compared to the latest forecast and the prior period.
Current constitutional documents
The Company’s Memorandum and Articles of Association can be found below along with the Certificate of Incorporation on Change of Name to Intercede Group plc.
Country of incorporation and main country of operation
Intercede is incorporated in the UK (Registration Number 4101977), which is also its main country of operation.
Find out the latest share price information from the London Stock Exchange.
Details of any other exchanges or trading platforms
The Company is not listed on any other exchanges or trading platforms.
Number of securities in issue
For details of the number of securities in issue, the number of securities held as treasury shares and, in so far as the Company is aware, the percentage of securities that is not in public hands together with the identity and percentage holdings of significant shareholders, see the major shareholders page.
Details of any restrictions on the transfer of securities
There are no restrictions on the transfer of securities.
See all news and notifications made by the Company.